Prismasol 4 Potassium Solution

Adult dosage

The flow rate of fluid substitute during blood filtration and dialysis is 500 - 3000 ml/h. For continuous blood dialysis and continuous blood dialysis filtration, the flow rate of the dialysis solution is 500 - 2500 ml/h. The commonly used flow rate in adults is about 2000 - 2500 mL/h, which corresponds to a total fluid substitute volume of about 48 - 60 L per day. When used intravenously and as a fluid substitute for dialysis, the blood

Children's dosage

The flow rate of fluid substitute during blood filtration and dialysis is 1000 - 2000 mL/h/1.73 m2. In particular, for younger children (≤10 kg), a maximum flow rate of 4000 mL/h/1.73 m2 is required.

This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to this medication or those with high serum potassium levels, or those with metabolic alkalosis. Moreover, it should not be used in patients whose azotemia is not corrected by blood filtration due to renal failure or in cases where arterial pressure is insufficient for vascular access. It should also be avoided in patients undergoing systemic anticoagulation therapy who are at high risk for bleeding. Various adverse reactions may occur during the use of this medication. Metabolic and nutritional-related adverse reactions such as fluid imbalance, electrolyte imbalance, hyperglycemia, and metabolic alkalosis have been reported. Hypotension, nausea, vomiting, and muscle cramps may also occur, thus caution is needed. This medication is used in blood filtration or dialysis treatment for patients with renal failure and must be administered under the supervision of a qualified physician. Serum potassium levels, hemodynamic status, fluid balance, electrolytes, and acid-base balance should be carefully monitored before and during treatment. Phosphate levels and blood sugar levels should be checked periodically, and special attention should be given to blood sugar control in diabetic patients. As this medication contains potassium, if hyperkalemia occurs, administration must be stopped immediately and appropriate measures should be taken to remove potassium if needed. This medication should not be used in patients with corn allergies, and if hypersensitivity reactions occur, administration must be stopped immediately. This medication can interact with other drugs, so dosage adjustments for medications being removed during dialysis may be necessary. Particularly, if sodium bicarbonate or buffers are added, the risk of metabolic alkalosis may increase, and the risk of hypercalcemia may also rise when used with calcium or vitamin D related drugs. There is insufficient safety data for patients who are pregnant or breastfeeding, so the benefits and risks should be carefully considered before administering this medication. In cases of overdose, fluid overload, electrolyte imbalance, and acid-base imbalance may occur, and in such cases, administration must be stopped immediately, and appropriate measures should be taken. Close monitoring during treatment is essential to prevent serious side effects from overdose. This medication must be used only in appropriate equipment and in a sterile environment, and the clarity and sealing status of the solution must be confirmed before administration. The mixed solution should be used immediately, and any remaining solution after use should be discarded. Furthermore, this medication should not be mixed with other drugs, and any mixing must be handled safely per the physician's instructions. During storage, it should be kept in a sealed container to prevent contact with air, and the storage temperature should be maintained between 4 degrees and 30 degrees Celsius. This will help preserve the medication's effectiveness.

Mild side effects

• Nausea
• vomiting
• muscle cramps
• hypotension
• fluid imbalance
• electrolyte imbalance
• hyperglycemia
• acid-base imbalance
• metabolic alkalosis
• hypophosphatemia

This medication should be stored in a sealed container to prevent contact with air, and the storage temperature must be maintained between 4 degrees and 30 degrees Celsius. This will help maintain the medication's efficacy.

Appearance

Slightly transparent yellow dialysis filtrate after mixing

Package unit

5000 ml/bag